04/13/2026
📣 ProSomnus Sleep Technologies Receives FDA Class II Clearance for RPMO2 OSA Device 📣
The ProSomnus RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision oral appliance therapy and multi-night physiologic monitoring in one device.
“The FDA’s clearance of the RPMO₂ OSA Device marks a significant milestone for sleep medicine,” stated Len Liptak, Chief Executive Officer of ProSomnus. “By integrating safe, accurate, continuous physiologic measurement into our precision oral appliance platform, we are enabling Smart Sleep Medicine—a connected, data driven model that helps clinicians manage sleep apnea as the personal, individualized and chronic disease it truly is.”
🔗Read the full press release here:
https://shorturl.at/SXD7e
✨Smart Sleep Medicine™ ✨